Combined Biomarker System Predicts Prognosis in Patients with Metastatic Oral Squamous Cell Carcinoma.
Tatjana KhromovLucas FischerAndreas LehaFelix BremmerAndreas FischerHenning SchliephakeMichal Amit RahatPhillipp BrockmeyerPublished in: Cancers (2023)
The combined marker system exhibited a significant ability to predict patient prognosis. An increase in EMMPRIN expression toward the IF showed the strongest effect and could be an interesting new antimetastatic therapy approach.
Keyphrases